Fingolimod Capsule
Product Images NDC 0480-7820

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 0480-7820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

Chemical structure of fingolimod hydrochloride, showing its molecular formula C19H33NO2·HCl and its structural arrangement with aromatic and hydroxyl groups.*

FDA Label Image

Figure-revised (Image 2)

A line graph depicting the percentage of patients with three-month confirmed progression over time in days, comparing Fingolimod 0.5 mg versus placebo groups. The x-axis shows time up to 720 days, and the y-axis shows the percentage of patients progressing. Fingolimod shows approximately 18% progression, while placebo reaches about 24%.*

FDA Label Image

0.5mg30s (Image 3)

Label for Fingolimod Capsules 0.5 mg by Teva Pharmaceuticals, Inc. The label includes the product name, strength, dosage form as capsules, and states 'Rx only' with a package size of 30 capsules. It also contains usage instructions, storage conditions, and a lot/expiration coding area. The Teva logo is displayed in green.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.